Everest Medicines Limited (HKG:1952)
23.12
-0.98 (-4.07%)
Jun 26, 2026, 4:08 PM HKT
Everest Medicines Employees
Everest Medicines had 812 employees as of December 31, 2025. The number of employees increased by 147 or 22.11% compared to the previous year.
Employees
812
Change (1Y)
147
Growth (1Y)
22.11%
Revenue / Employee
2.34M HKD
Profits / Employee
-408.08K HKD
Market Cap
8.13B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| CARsgen Therapeutics Holdings | 355 |
| Suzhou Ribo Life Science | 407 |
| HBM Holdings | 272 |
| CStone Pharmaceuticals | 136 |
| Shanghai Haohai Biological Technology | 2,110 |
| Abbisko Cayman | 276 |
| Alphamab Oncology | 498 |
| Lepu Biopharma | 710 |
Everest Medicines News
- 20 days ago - LENZ Therapeutics Secures $85 Million Potential from Everest Medicines Deal - GuruFocus
- 20 days ago - Everest Medicines Acquires Rights To Develop And Commercialize VIZZ In Greater China - Nasdaq
- 20 days ago - LENZ Announces Everest Medicines' Acquisition of VIZZ Rights in Greater China - GuruFocus
- 26 days ago - Travere Therapeutics Partners with Everest Medicines for $1.14 Billion Kidney Drug Deal - GuruFocus
- 2 months ago - Everest Medicines Slides: Acquisition presentation - Filings
- 2 months ago - China biotech flow picks up as Everest seals US$250 million deal - South China Morning Post
- 3 months ago - Everest Medicines Earnings release: H2 2025 - Filings
- 3 months ago - Everest Medicines Slides: H2 2025 - Filings